Previous Article | Next Article 
Applied and Environmental Microbiology, February 2000, p. 638-642, Vol. 66, No. 2
0099-2240/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
A Protein Disulfide Isomerase Gene Fusion
Expression System That Increases the Extracellular Productivity of
Bacillus brevis
Tsutomu
Kajino,1,*
Chikara
Ohto,2
Masayoshi
Muramatsu,2
Shusei
Obata,2
Shigezo
Udaka,3
Yukio
Yamada,1 and
Haruo
Takahashi1
Toyota Central Research & Development
Laboratories, Inc., Nagakute, Aichi 480-1192,1
Bio Research Lab, Toyota Motor Corporation, Toyota, Aichi
471-8572,2 and Department of
Fermentation Science, Tokyo University of Agriculture, Setagaya, Tokyo
156-8502,3 Japan
Received 30 August 1999/Accepted 30 November 1999
 |
ABSTRACT |
We have developed a versatile Bacillus brevis
expression and secretion system based on the use of fungal protein
disulfide isomerase (PDI) as a gene fusion partner. Fusion with PDI
increased the extracellular production of heterologous proteins (light
chain of immunoglobulin G, 8-fold; geranylgeranyl pyrophosphate
synthase, 12-fold). Linkage to PDI prevented the aggregation of the
secreted proteins, resulting in high-level accumulation of fusion
proteins in soluble and biologically active forms. We also show that
the disulfide isomerase activity of PDI in a fusion protein is
responsible for the suppression of the aggregation of the protein with
intradisulfide, whereas aggregation of the protein without
intradisulfide was prevented even when the protein was fused to a
mutant PDI whose two active sites were disrupted, suggesting that
another PDI function, such as chaperone-like activity, synergistically
prevented the aggregation of heterologous proteins in the PDI fusion
expression system.
 |
INTRODUCTION |
A host-vector system for the
efficient extracellular production of heterologous proteins, involving
Bacillus brevis as the host, has been developed
(22). Many proteins of bacterial origin could be produced at
high levels without much difficulty. However, certain proteins,
especially some mammalian ones, still exhibited low productivity.
Sagiya et al. improved the B. brevis protein expression
system by means such as modification of the signal sequence
(17) and isolation of a protease-deficient mutant
(7), which was successfully applied to the secretion and
accumulation of not only prokaryotic but also eukaryotic proteins. In
fact, a change of the signal peptide sequence in the B. brevis system resulted in the higher secretion of many proteins,
for example, growth hormones (7, 17), interleukin 2 (21), and protein disulfide isomerase (PDI) (8),
and the use of protease-deficient mutants increased the production of
extracellular proteins (6, 7). Still another way of
increasing protein productivity is to link the gene of interest to a
second gene which is already known to be expressed well in the host to
generate a fusion protein (9). In most of the successful
fusion protein systems the protein of interest is positioned at the
C-terminal end of the highly expressed fusion partner (12,
19) to ensure efficient translation initiation. The thioredoxin
gene fusion system also provided the solution for another major problem
which has bedeviled heterologous gene expression in E. coli,
i.e., the formation of inclusion bodies (11). PDI catalyzes
the formation, reduction, and isomerization of disulfide bonds in vitro
(5) and facilitates the folding of disulfide-bonded proteins
in vivo (18). Even though the physiological roles of these
multiple functions of PDI during protein folding in the cell remain
obscure, PDI, promoting in vitro folding, can be used to improve an
expression system for foreign genes. In fact, in a coexpression system,
PDI exhibits chaperone-like activity which suppresses the aggregation
and increases the yields of heterologous proteins (3, 4).
In this paper, we describe a novel fusion gene expression system based
on the use of thermostable PDI as a fusion partner and also report the
effect of the disulfide oxidoreductase activity of the fused PDI as to
increases in the production of the light chain of immunoglobulin G
(IgG) against 11-deoxycortisol, as a disulfide-bonded protein, and
geranylgeranyl pyrophosphate synthase (GGPS) from an extremely
thermophilic archaea, Sulfolobus acidocaldarius, as a
non-disulfide-bonded protein.
 |
MATERIALS AND METHODS |
Strains, plasmids, and media.
B. brevis 31-OK was used
as the host (7). Plasmid pNU212 is an expression-secretion
vector containing a multiple promoter region and the signal
peptide-encoding region of the gene that codes for middle wall protein
(MWP) (22) of B. brevis 47. pNH326 was
constructed from pNH300 (16) by replacing the MWP signal peptide with a modified signal peptide, R2L6 (17), and by
adding the transcription terminator of pHT926 (2). Plasmids
pNU211L4PDI (8) and pMalcGG2 (15), containing the
fungal PDI gene and the archaeal GGPS gene, respectively, were
described previously. Plasmid pFCA-SCHL (13) contained the
gene encoding the LC, a chimeric protein of the
VL-CL domain of anti-11-deoxycortisol Fab and
the two Fc binding domains of protein A from Staphylococcus aureus. For the expression of LC, DNA fragments encoding LC were amplified by PCR, for which pFCA-SCHL was used as a template and synthetic oligonucleotides 5'-CCGCCCATGGCTTTCGCTGACATCGAGCTCACC-3' (named MWPLC) and
5'-GCCGCTCGAGAAGCTTTATTAATTCGCGTCTACTTTCGGCGCCTGAGC-3' (named LCSTOP)
were used as primers. The nucleotide sequence of MWPLC comprises the 3'
terminal sequence of the signal-peptide-encoding region of the
mwp gene directly connected to the sequence encoding the N
terminus of the LC. An NcoI site is present at its 5' end. The nucleotide sequence of LCSTOP is complementary to that encoding the
C terminus of the LC. A stop codon and the HindIII site
sequence are attached to its 5' end. The amplified fragment was
digested with NcoI and HindIII and then
inserted between the NcoI and HindIII sites
of pNH326. The plasmid thus constructed was named pNH326LC (Fig.
1A). The fragment comprising the region
from SD to the 3' terminus of the PDI-encoding sequence of pNU211L4PDI,
an expression vector of PDI, was amplified by PCR, for which the
oligonucleotides 5'-CTCGAGAAGCTTAGAGCAGGAGAACACAAGGTATGAAA-3'
(named SDMWP) and 5'-GCCAAGCTTATTGAGCTCGTCGTGCTCCGTCGCCGTCTCC-3' (named
PDISTOP) were used. The sequence of SDMWP is comprised of that around
SD of the mwp gene with a HindIII site
attached to its 5' end. The sequence of PDISTOP is complementary to
that encoding the C terminus of PDI. A HindIII site
sequence was attached to its 5' end. The amplified fragment was
digested with XhoI and HindIII and then inserted between the XhoI site, located immediately
downstream of the sequence encoding the LC, and the
HindIII site of pNH326LC. The constructed plasmid was
named pNH326LC/PDI (Fig. 1A).

View larger version (32K):
[in this window]
[in a new window]
|
FIG. 1.
Structures of the expression and secretion vectors. (A)
Structure of the vector for LC expression. SD, ribosome-binding site of
the middle wall protein; SP, signal-peptide-encoding sequence; LC,
LC-encoding sequence; Nm, neomycin resistance gene; Pr, promoter of the
cell wall protein gene operon in B. brevis; Ori, replication
origin. The nucleotide and amino acid sequences of the regions denoted
by a, b, c, and d are shown below. *, stop codon. (B) Structure of
pNH326PDI-GGPS. The abbreviations and symbols are the same as above.
|
|
By essentially the same procedures, a DNA fragment encoding GGPS was
amplified from pMalcGG2 as a template with oligonucleotides
5'-CCGCCCATGGCTTTCGCTATGAGTTACTTTGACAACTA-3' (named MWPGGPS)
and
5'-GCCAAGCTTATTCTTATTTTC-3' (named GGPSSTOP) as primers.
The DNA
fragment was inserted into pNU212, and the resulting plasmid
was
named pNU212GGPS. The expression vectors for PDI fusion proteins
are described under Results. All the plasmids were introduced
into
B. brevis by electroporation (
16).
YC medium was comprised of 30 g of polypeptone P1 (Nihon
Pharmaceuticals, Tokyo, Japan), 2 g of yeast extract, 30 g of
glucose,
0.1 g of CaCl
2 · 2H
2O,
0.1 g of MgSO
4 · 7H
2O, 10 mg of
FeSO
4 ·
7H
2O, 10 mg of
MnSO
4 · 4H
2O, and 1 mg of
ZnSO
4 · 7H
2O per liter,
pH 7.2. YC-P2
medium was the same as YC medium except that the
polypeptone content
was 20
g.
Enterokinase cleavage.
A supernatant containing the PDI-LC
fusion protein was dialyzed against EK buffer (5 mM EDTA, 25 mM
HEPES-NaOH [pH 8.0]) prior to enterokinase cleavage. The dialyzed
culture supernatant was then mixed with porcine enterokinase (specific
activity, 100 U/mg; Sigma) in EK buffer at an enzyme-to-substrate ratio
of 1:100 (wt/wt) and then incubated at 37°C for 15 h. The
reaction was terminated by the addition of
p-aminobenzamidine to 5 mM.
Analysis of the expressed proteins.
The amounts of the
expressed proteins were routinely determined by Western blot analysis
according to the method of Burnette (1), except that an
anti-Fab fragment polyclonal antibody, as the primary antibody, and an
alkaline phosphatase-conjugated goat anti-rabbit IgG, as the secondary
antibody, were used for detection of the LC. Rabbit anti-GGPS fused to
maltose binding protein antiserum (15) and an alkaline
phosphatase-conjugated goat anti-rabbit IgG monoclonal
(Fab')2 were used as the primary and secondary antibodies,
respectively, for GGPS detection. BCIP-NBT (5-bromo-4-chloro-3-indolylphosphate-nitroblue tetrazolium) was used
as the substrate for the color reaction. Sodium dodecyl
sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) was performed
according to the method of Laemmli (10). For nonreducing
SDS-PAGE, dithiothreitol was omitted from the sample buffer. The PDI
activity of the fused protein was assayed with scrambled RNase as a
substrate according to the method described previously (20).
GGPS activity was assayed by the method described previously
(15).
 |
RESULTS |
Construction of genes encoding fusion proteins.
DNA fragments
encoding fusion proteins PDI-LC and PDI-GGPS were constructed by the
recombinant PCR method. The DNA fragment encoding PDI was amplified
with MWPPDI
(5'-CCGCCCATGGCTTTCGCTTCGGATGTTGTCCAGCTGAAGA AGG-3')
and PDIEK
(5'-CTTGTCATCGTCATCACCAGAACCAGAACCGAGCTCGTCGTGCTCCGTCGCCGTCTC C-3')
as primers and pNU211L4PDI as a template. The DNA fragment encoding LC was also amplified with a template, pFCA-SCHL, and primers
EKLC
(5'-GGTTCTGGTTCTGGTGATGACGATGACAAGGACATCGAGCTCACCCAGT CTCCAGCC-3')
and LCSTOP (described under Materials and Methods). In the
amplified DNA, a polylinker region was joined to the 3' end of the PDI
gene and to the 5' end of the LC gene. The DNA fragment encoding the
PDI-LC fusion protein was amplified by recombinant PCR with DNAs that
were prepared as described above as templates and MWPPDI and LCSTOP as
primers. The LC gene was connected in-frame to the C-terminal-encoding
end of the PDI gene through a linker sequence. The polylinker peptide
was composed of the sequence DDDDK, which is the recognition sequence
for the mammalian intestinal protease, enterokinase, to separate PDI
from the fusion protein. PDI-LC DNA was digested with NcoI
and HindIII and then inserted between the
NcoI and HindIII sites of pNH326, an
expression vector for B. brevis. The plasmid thus
constructed was named pNH326PDI-LC (Fig. 1A).
pNH326PDI-GGPS (Fig.
1B), the expression vector of the PDI-GGPS fusion
protein, was constructed in same way as for PDI-LC
with EKGGPS
(5'-GGTTCTGGTTCTGGTGATGACGATGACAAGATGAGTTACTTTGACAACTA-3') and
GGPSSTOP
(described under Materials and Methods) as primers and
pMalcGG2 as a
template.
Production of fusion proteins.
The expression vector for LC or
GGPS was introduced into B. brevis. Clones expressing the
fusion proteins were grown under various conditions, and then the
amounts of extracellular fusion proteins were estimated from the
intensities of the bands obtained by Western blot analysis or
calculated on the basis of the specific activity of the purified enzyme
(Table 1). Clones expressing a
heterologous protein by itself or coexpressing PDI and LC were also
cultured under the same conditions to compare their productivities with
fusion expression. The maximum amounts of LC expressed by itself and
coexpressed with PDI were only 20 and 10 mg/liter, respectively, even
in YC-P2 medium containing 0.3% Tween 40, which was effective for
increasing the production levels of some mammalian proteins
(21). The addition of PEG 4000 or EDTA, which were also
effective for increasing the productivity, also did not increase the
productivity, whereas the production level of PDI-LC reached 150 mg/liter. On the other hand, the amounts of extracellular GGPS and
GGPS-PDI were 8 and 100 mg/liter, respectively. Thus, the production of
LC and GGPS, when expressed as fusion proteins with PDI, was about 8 and 12 times, respectively, greater than when they were expressed by
themselves.
The cellular locations of proteins synthesized alone or as fusions with
PDI were compared by Western blot analysis (Fig.
2).
Each secreted mature-sized protein
(LC, GGPS, PDI-LC, or PDI-GGPS)
was naturally detected in the culture
supernatant. Although the
mature-sized heterologous protein was also
detected in the insoluble
fraction after expression by itself and
coexpression with PDI,
neither the mature form nor the precursor form
of the fusion protein
was observed in the insoluble fraction. These
findings suggest
that the fusion with PDI suppresses the aggregation of
secreted
LC and GGPS, resulting in increases in the amounts of the
extracellular
active forms.

View larger version (32K):
[in this window]
[in a new window]
|
FIG. 2.
Localization of heterologous proteins expressed by
B. brevis. B. brevis 31-OK cells carrying pNH326LC,
pNH326LC/PDI, pNH326PDI-LC, pNU212GGPS, or pNH326PDI-GGPS
were grown for 6 days at 30°C in YC-P2 medium containing 0.3% Tween
40. The culture supernatant was used as the soluble fraction. The cell
pellet was suspended in the same volume as the culture of the sample
buffer (62.5 mM Tris-HCl [pH 6.7], 1% SDS, 5% -mercaptoethanol)
and then sonicated. This suspension was incubated in boiling water for
2 min and then centrifuged. The resulting supernatant was used as the
insoluble fraction. Ten microliters of each of the insoluble and
soluble fractions was subjected to SDS-PAGE, followed by immunoblot
analysis as described under Materials and Methods. The gels show the
localization of LC (A) and GGPS (B). Lanes 1, 3, and 5, insoluble
fraction expressed by itself, expressed as a fusion form with PDI, and
coexpressed with PDI, respectively; lanes 2, 4, and 6, soluble fraction
expressed by itself, expressed as a fusion form with PDI, and
coexpressed with PDI, respectively.
|
|
The effect of the oxidoreductase activity of PDI on the formation
of insoluble aggregates.
PDI used as a fusion partner contains two
CGHC catalytic sites and can act as an oxidoreductase. When the
cysteine residues in each active site of PDI were changed to serine
ones (SGHS), the oxidoreductase activity was lost. It has been reported
that PDI exhibits chaperone-like activity, e.g., it suppresses
rhodanase aggregation in yeast (9), and that the
chaperone-like activity of PDI remains unaffected even when both its
active sites are changed to SGHS (12). To clarify what
function of PDI suppresses aggregation of fusion proteins, LC and GGPS
fused with the mutant PDI (mPDI), whose two catalytic site sequences
were substituted with SGHS, were expressed in B. brevis. We
confirmed that the chimeric proteins fused with mPDI had completely
lost their isomerase activity while that of the native PDI fusion
remained unaffected. The fusion with mPDI had no effect on the high
level of extracellular production of the PDI-GGPS fusion protein (Fig.
3, lanes 3 and 4), indicating that the
isomerase activity of PDI is not responsible for the increase in the
production of PDI-GGPS, whereas the fusion with mPDI made aggregates
appear in the insoluble fraction and decreased the production of
soluble PDI-LC in the extracellular fraction (Fig. 3, lanes 1 and 2).
These results suggested that the oxidoreductase activity of PDI in the
fusion proteins was partly responsible for the suppression of the
aggregation of the proteins with disulfides, such as the LC of an IgG,
but not those without disulfides, such as GGPS.

View larger version (34K):
[in this window]
[in a new window]
|
FIG. 3.
The effect of oxidoreductase activity on aggregate
formation. B. brevis 31-OK cells carrying the expression
vector for LC or GGPS fused to the native or mutant PDI, respectively,
were cultured and treated as described in the legend to Fig. 2. Ten
microliters of each of the insoluble and soluble fractions of LC (A)
and GGPS (B) was analyzed by SDS-PAGE, followed by immunostaining as
described under Materials and Methods. Lanes 1 and 3, the accumulated
protein fused to the native and mutant PDI, respectively, in the
insoluble fraction; lanes 2 and 4, the secreted protein fused to the
native and mutant PDI, respectively, in the soluble fraction.
|
|
Characterization of the fusion proteins.
The fusion proteins
produced by B. brevis were examined as to their biological
functions. The expressed LC could not assemble with the heavy chain
(HC) in the fusion form. PDI-LC was incubated with bovine enterokinase.
PDI-LC was successfully cleaved specifically at the cleavage site in
the linker peptide, resulting in a 40-kDa product corresponding to the
native LC, as in the case of that expressed by itself (Fig.
4). The LC cleaved from the fusion
protein exhibited significant assembly with HC, forming a 70-kDa
product corresponding to the Fab' form under nonreducing conditions
(data not shown), whereas PDI-GGPS produced by B. brevis
exhibited the same GGPS activity as the native GGPS throughout the
temperature range examined (Fig. 5).
PDI-GGPS specifically produced geranylgeranyl diphosphate from
an allylic diphosphate (data not shown). These results indicate that
the fusion protein showed the same properties in the fusion form as
native archaeal GGPS (14).

View larger version (66K):
[in this window]
[in a new window]
|
FIG. 4.
Specific cleavage of the PDI-LC fusion protein by
enterokinase. An immunostained SDS-polyacrylamide gel (see Materials
and Methods) is shown. Lane 1, marker proteins; lane 2, PDI-LC secreted
by B. brevis; lane 3, PDI-LC following cleavage with
enterokinase.
|
|

View larger version (15K):
[in this window]
[in a new window]
|
FIG. 5.
Optimal reaction temperature of PDI-GGPS. Using 50 mM
bis-Tris propane (pH 9.5), PDI-GGPS produced by B. brevis
was reacted with [14C]isopentenyl diphosphate,
dimethylallyl diphosphate, and 5 mM MgCl2 for 30 min at the
indicated temperatures. The reaction products were extracted with
H2O-saturated butanol, and then the radioactivity of the
products was measured with a liquid scintillation counter. The activity
at 40°C was defined as 1. Closed and open circles indicate GGPS fused
to PDI and native GGPS from the archaea, respectively. The data are the
means of at least four independent experiments.
|
|
 |
DISCUSSION |
We succeeded in the efficient secretion and accumulation of the
soluble forms of an LC of IgG and an archaeal GGPS by means of a PDI
fusion system in B. brevis. PDI has at least two
characteristics which may make it a particularly suitable choice for
the fusion partner. PDI of H. insolens, a thermophilic
fungus, can be secreted and accumulated in the culture medium to a
concentration of up to 1.1 g/liter by B. brevis, and even at
this production level, all of the PDI remains in a soluble form
(8). It was thought that the secretion is affected by the
sequence of the signal peptide and the following N-terminal sequence of
the protein of interest. It is, however, generally undesirable to
change the sequence of a protein to increase its secretion since the
N-terminal sequence following the signal peptide is often responsible
for the function of the protein of interest. When a fusion protein is
expressed, more stable secretion can be expected because the signal
peptide can be tuned up to result in efficient secretion of the
N-terminal fusion partner regardless of the sequence of the partner.
Thus, PDI can act as a leader peptide, which allows efficient secretion of heterologous proteins.
There is another advantage that a PDI fusion can provide: it can act as
a molecular chaperone which prevents aggregation and facilitates
correct folding. The aggregation of secreted proteins is one of the
causes of a decrease in extracellular productivity. In some cases of
heterologous protein expression by B. brevis, mature-sized
heterologous proteins in the insoluble fraction have been obtained. It
is possible that by physically linking a heterologous protein to a
stable and highly soluble fusion partner such as PDI, these aggregates
might be prevented from forming, allowing correct folding to occur
eventually. The fact that PDI is secreted first may allow it to fold
before its nascent C-terminal fusion partner, and in this way it is
able to passively interact with the partner as it emerges from the
outer membrane. In contrast to coexpressed PDI, expression as a fusion
form would enable close physical contact between PDI and the
heterologous protein domain, facilitating any potential interaction.
The enhanced extracellular production of the soluble LC by B. brevis required a physical linkage to PDI and could not be
accomplished through coexpression of PDI, suggesting that the PDI
domain acts as a covalently linked chaperone. The mechanism suppressing
the aggregation through fusion with PDI was not elucidated.
We showed that the oxidoreductase activity of PDI was partially
responsible for the suppression of the aggregation of the secreted LC,
a protein containing intradisulfides, whereas the aggregation of GGPS,
a protein without intradisulfides, could be prevented even with the
fusion with PDI lacking oxidoreductase activity (SGHS). From these
results, we can speculate that PDI prevents the aggregation of a fusion
partner through the synergistic effect of its oxidoreductase and its
other chaperone-like activity, leading to an increase in the
extracellular production of a heterologous protein. Although each
domain of PDI and GGPS in the fusion protein exhibited the expected
biological function, the LC did not. Partial biological activity is not
unexpected for fusion proteins, since some functional site may be
masked by the fusion partner. However, the LC, while inactive in a
fusion form, exhibited significant biological activity when cleaved
from its partner. This suggests that both PDI and the fused
heterologous protein are able to fold correctly when linked together.
The PDI used as a fusion partner is a thermostable PDI from a
thermophilic fungus and seems to have a very tight tertiary fold,
judging from its thermal stability. This folding property is probably
very resistant to any perturbation that may be caused by the presence
of fused heterologous proteins. This may be the underlying reason why
thermostable PDI is such a good fusion partner.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Toyota Central
Research & Development Laboratories, Inc., Nagakute, Aichi 480-1192, Japan. Phone: 81-561-63-8491. Fax: 81-561-63-6498. E-mail:
e0846{at}mosk.tytlabs.co.jp.
 |
REFERENCES |
| 1.
|
Burnette, W. N.
1981.
"Western blotting": electrophoretic transfer of proteins from sodium dodecyl sulfate-polyacrylamide gels to unmodified nitrocellulose, and radiographic detection with antibodies and radioiodinated protein A.
Anal. Biochem.
112:195-203[CrossRef][Medline].
|
| 2.
|
Ebisu, S.,
Y. Murahashi,
H. Takagi,
K. Kadowaki,
K. Yamaguchi,
H. Yamagata, and S. Udaka.
1995.
Nucleotide sequence and replication properties of the Bacillus borstelensis cryptic plasmid pHT926.
Appl. Environ. Microbiol.
61:3154-3157[Abstract].
|
| 3.
|
Gilbert, H. F.
1999.
Protein disulfide isomerase and assisted protein folding.
J. Biol. Chem.
272:29399-29402[Free Full Text].
|
| 4.
|
Hayano, T.,
M. Hirose, and M. Kikuchi.
1995.
Protein disulfide isomerase mutant lacking isomerase activity accelerates protein folding in the cell.
FEBS Lett.
377:505-511[CrossRef][Medline].
|
| 5.
|
Hillson, D. A.,
N. Lambert, and R. B. Freedman.
1984.
Formation and isomerization of disulfide bonds in proteins: protein disulfide-isomerase.
Methods Enzymol.
107:281-294[Medline].
|
| 6.
|
Inoue, Y.,
T. Ohta,
H. Tada,
S. Iwasa,
S. Udaka, and H. Yamagata.
1997.
Efficient production of a functional mouse/human chimeric Fab' against human urokinase-type plasminogen activator by Bacillus brevis.
Appl. Microbiol. Biotechnol.
48:487-492[Medline].
|
| 7.
|
Kajino, T.,
Y. Saito,
M. Hirai,
O. Asami,
Y. Yamada, and S. Udaka.
1997.
Extracellular production of an intact and biologically active human growth hormone by the Bacillus brevis system.
J. Ind. Microbiol. Biotechnol.
19:227-231[Medline].
|
| 8.
|
Kajino, T.,
K. Kato,
C. Miyazaki,
O. Asami,
Y. Yamada,
M. Hirai, and S. Udaka.
1998.
Isolation of a protease-deficient mutant of Bacillus brevis and efficient secretion of a fungal protein disulfide isomerase by the mutant.
J. Biosci. Bioeng.
87:37-42[CrossRef].
|
| 9.
|
Kato, M.,
Y. Fujiwara,
A. Okamoto,
M. Yoshikawa,
H. Chiba, and S. Udaka.
1995.
Efficient production of Casoxin D, a bradykinin agonist peptide derived from human casein, by Bacillus brevis.
Biosci. Biotech. Biochem.
59:2056-2059[Medline].
|
| 10.
|
Laemmli, U. K.
1970.
Cleavage of structural proteins during the assembly of the head of bacteriophage T4.
Nature
227:680-685[CrossRef][Medline].
|
| 11.
|
LaValli, E. R.,
E. A. DiBlasco,
S. Kovacic,
K. L. Grant,
P. F. Schendel, and J. McCoy.
1993.
A thioredoxin gene fusion expression system that circumvents inclusion body formation in E. coli cytoplasm.
Bio/Technology
11:187-193[CrossRef][Medline].
|
| 12.
|
Maina, C. V.,
P. D. Riggs,
A. G. Grandea,
B. E. Slatko,
L. S. Moran,
J. A. Tagliamonte,
L. A. McReynolds, and C. di Guan.
1988.
An Escherichia coli vector to express and purify foreign proteins by fusion to and separation from maltose-binding protein.
Gene
74:365-373[CrossRef][Medline].
|
| 13.
|
Miyazaki, C.,
Y. Iba,
Y. Yamada,
H. Takahashi,
J. Sawada, and Y. Kurosawa.
1999.
Changes in the specificity of antibodies by site-specific mutagenesis followed by random mutagenesis.
Protein Eng.
12:407-415[Abstract/Free Full Text].
|
| 14.
|
Ohnuma, S.,
M. Suzuki, and T. Nishino.
1994.
Archaebacterial ether-linked lipid biosynthetic gene. Expression cloning, sequencing, and characterization of geranylgeranyl-diphosphate synthase.
J. Biol. Chem.
269:14792-14797[Abstract/Free Full Text].
|
| 15.
|
Ohto, C.,
H. Nakane,
H. Hemmi,
S. Ohnuma,
S. Obata, and T. Nishino.
1998.
Overexpression of an archaeal geranylgeranyl diphosphate synthase in Escherichia coli cells.
Biosci. Biotech. Biochem.
62:1243-1246[CrossRef][Medline].
|
| 16.
|
Okamoto, A.,
A. Kosugi,
Y. Koizumi,
F. Yanagida, and S. Udaka.
1997.
High efficiency transformation of Bacillus brevis by electroporation.
Biosci. Biotech. Biochem.
61:202-203[Medline].
|
| 17.
|
Sagiya, Y.,
H. Yamagata, and S. Udaka.
1994.
Direct high-level secretion into the culture medium of tuna growth hormone in a biologically active form by Bacillus brevis.
Appl. Microbiol. Biotechnol.
42:358-363[Medline].
|
| 18.
|
Shusta, E. V.,
R. T. Rains,
A. Pluckthun, and K. D. Wittrup.
1998.
Increasing the secretory capacity of Saccharomyces cerevisiae for the production of single-chain antibody fragments.
Nat. Biotechnol.
16:773-777[CrossRef][Medline].
|
| 19.
|
Smith, D. B., and K. S. Johnson.
1988.
Single-step purification of polypeptides expressed in Escherichia coli as fusions with glutathione-S-transferase.
Gene
67:31-40[CrossRef][Medline].
|
| 20.
|
Sugiyama, H.,
C. Idekoba,
T. Kajino,
F. Hoshino,
O. Asami,
Y. Yamada, and S. Udaka.
1993.
Purification of protein disulfide isomerase from a thermophilic fungus.
Biosci. Biotech. Biochem.
57:1704-1707[Medline].
|
| 21.
|
Takimura, Y.,
M. Kato,
T. Ohta,
H. Yamagata, and S. Udaka.
1997.
Secretion of human interleukin-2 in a biologically active form by Bacillus brevis directly into the culture medium.
Biosci. Biotech. Biochem.
61:1858-1861[Medline].
|
| 22.
|
Udaka, S., and H. Yamagata.
1993.
High-level secretion of heterologous proteins by Bacillus brevis.
Methods Enzymol.
217:23-33[Medline].
|
Applied and Environmental Microbiology, February 2000, p. 638-642, Vol. 66, No. 2
0099-2240/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.